Table 4.
Patterns of medication use
| Medication n (%) | Preadmission | Hospital Discharge | 1-Year Postdischargea | |||||
|---|---|---|---|---|---|---|---|---|
| AKI Follow-Up Clinic (n=34) | Usual Care (n=37) | AKI Follow-Up Clinic (n=34) | Usual Care (n=37) | P Valueb | AKI Follow-Up Clinic (n=34) | Usual Care (n=37) | P Valueb | |
| ACEi or ARB | 20 (59) | 23 (62) | 9 (27) | 15 (41) | 0.22 | 12 (35) | 18 (49) | 0.27 |
| Statin | 20 (59) | 21 (57) | 23 (68) | 24 (65) | 0.94 | 19 (56) | 23 (62) | 0.34 |
| β-Blocker | 12 (35) | 15 (40) | 17 (50) | 18 (49) | 0.66 | 17 (50) | 18 (49) | 0.73 |
| Calcium channel blocker | 5 (15) | 12 (32) | 7 (21) | 14 (38) | 0.54 | 7 (21) | 10 (27) | 0.57 |
| Loop diuretic | 4 (12) | 10 (27) | 9 (27) | 17 (46) | 0.30 | 8 (24) | 16 (43) | 0.38 |
| Thiazide | 8 (24) | 5 (14) | 2 (6) | 2 (5) | 0.75 | 4 (12) | 5 (14) | 0.40 |
| Spironolactone | 3 (9) | 2 (5) | 4 (12) | 5 (14) | 0.53 | 3 (9) | 5 (14) | 0.42 |
| Metformin | 12 (35) | 11 (30) | 11 (32) | 7 (19) | 0.16 | 11 (32) | 6 (16) | 0.10 |
| Oral hypoglycemic agent | 6 (18) | 6 (16) | 7 (21) | 4 (11) | 0.14 | 9 (27) | 7 (19) | 0.34 |
| NSAIDs | 5 (15) | 4 (11) | 0 (0) | 1 (3) | 0.36 | 1 (3) | 3 (8) | 0.34 |
ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; NSAIDs, nonsteroidal anti-inflammatory drugs.
a
For patients without 1-year data (died [n=7] or missing [n=8]), the last prior outpatient record was carried forward.
b
Mantel–Haenszel test stratified by preadmission medication status.